Literature DB >> 28676207

Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitis.

Robert D Pesek1, Mallikarjuna Rettiganti2, Erin O'Brien3, Sarah Beckwith3, Caroline Daniel3, Chunqiao Luo2, Amy M Scurlock3, Peggy Chandler3, Rebecca A Levy4, Tamara T Perry3, Joshua L Kennedy3, Sheva Chervinskiy3, Maryelle Vonlanthen5, Helen Casteel5, Stephen C Fiedorek6, Troy Gibbons7, Stacie M Jones3.   

Abstract

BACKGROUND: In children with eosinophilic esophagitis (EoE) foods are the most common disease triggers, but environmental allergens are also suspected culprits.
OBJECTIVE: To determine the effects of environmental allergen sensitization on response to treatment in children with EoE in the southeastern United States.
METHODS: Patients 2 to 18 years old who were referred to the Arkansas Children's Hospital Eosinophilic Gastrointestinal Disorders Clinic from January 2012 to January 2016 were enrolled in a prospective, longitudinal cohort study with collection of demographics, clinical symptoms, medical history, allergy sensitization profiles, and response to treatment over time. Comparisons were made between complete responders (peak esophageal eosinophil count <15 per high-power field [HPF]) and nonresponders (>25 eosinophils per HPF) after treatment with diet elimination alone, swallowed corticosteroids alone, or diet elimination and swallowed corticosteroids. Sensitization patterns to environmental allergens found in the southeastern United States were analyzed for the effect on treatment response.
RESULTS: A total of 223 individuals were enrolled. Of these, 182 had environmental allergy profiling and at least one endoscopy while receiving proton pump inhibitor (PPI) therapy. Twenty-nine individuals had PPI-responsive EoE and were excluded from further analysis, leaving 123 individuals with non-PPI-responsive EoE who were further analyzed; 72 (58.5%) were complete responders and 33 (26.8%) were nonresponders. Seventeen individuals (13.8%) were partial responders (≥1 but ≤25 eosinophils per HPF) and excluded from further analysis. Nonresponders were more likely to be sensitized to perennial allergens (P = .02). There was no significant difference in response based on seasonal allergen sensitization. Individuals with mold or cockroach sensitization were more likely to fail combination diet and swallowed corticosteroid treatment (P = .02 and P = .002).
CONCLUSION: Perennial allergen and mold sensitization may lead to nonresponse to EoE treatment in some patients. Additional studies are needed to further understand the effect of environmental allergens on EoE. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01779154.
Copyright © 2017 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28676207      PMCID: PMC6166246          DOI: 10.1016/j.anai.2017.06.006

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  35 in total

1.  Eosinophilic esophagitis: a 10-year experience in 381 children.

Authors:  Chris A Liacouras; Jonathan M Spergel; Eduardo Ruchelli; Ritu Verma; Maria Mascarenhas; Edisio Semeao; Jonathan Flick; Janice Kelly; Terry Brown-Whitehorn; Petar Mamula; Jonathan E Markowitz
Journal:  Clin Gastroenterol Hepatol       Date:  2005-12       Impact factor: 11.382

2.  Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States.

Authors:  Jonathan M Spergel; Wendy M Book; Elizabeth Mays; Lihal Song; Samir S Shah; Nicholas J Talley; Peter A Bonis
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

3.  Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet.

Authors:  Jonathan M Spergel; Terri F Brown-Whitehorn; Antonella Cianferoni; Michele Shuker; Mei-Lun Wang; Ritu Verma; Chris A Liacouras
Journal:  J Allergy Clin Immunol       Date:  2012-06-27       Impact factor: 10.793

4.  Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice.

Authors:  Anil Mishra; James Schlotman; Meiqin Wang; Marc E Rothenberg
Journal:  J Leukoc Biol       Date:  2006-12-28       Impact factor: 4.962

5.  Eosinophilic esophagitis in children and adolescents: epidemiology, clinical presentation and seasonal variation.

Authors:  Serge Alexander Sorser; Mohammed Barawi; Karen Hagglund; Mohammad Almojaned; Hernando Lyons
Journal:  J Gastroenterol       Date:  2012-05-23       Impact factor: 7.527

6.  De-novo onset of eosinophilic esophagitis after large volume allergen exposures.

Authors:  W Asher Wolf; Maya R Jerath; Evan S Dellon
Journal:  J Gastrointestin Liver Dis       Date:  2013-06       Impact factor: 2.008

7.  The predictive value of allergen skin prick tests and IgE tests at pre-school age: the PACT study.

Authors:  Anne Dorthea Rø; Melanie Rae Simpson; Ola Storrø; Roar Johnsen; Vibeke Videm; Torbjørn Øien
Journal:  Pediatr Allergy Immunol       Date:  2014-11-21       Impact factor: 6.377

8.  Comparative degree and type of sensitization to common indoor and outdoor allergens in subjects with allergic rhinitis and/or asthma.

Authors:  L P Boulet; H Turcotte; C Laprise; C Lavertu; P M Bédard; A Lavoie; J Hébert
Journal:  Clin Exp Allergy       Date:  1997-01       Impact factor: 5.018

9.  Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis.

Authors:  Gita Ram; Juhee Lee; Megan Ott; Terri F Brown-Whitehorn; Antonella Cianferoni; Michele Shuker; Mei-Lun Wang; Ritu Verma; Chris A Liacouras; Jonathan M Spergel
Journal:  Ann Allergy Asthma Immunol       Date:  2015-07-30       Impact factor: 6.347

10.  The 2010-2015 Prevalence of Eosinophilic Esophagitis in the USA: A Population-Based Study.

Authors:  Emad Mansoor; Gregory S Cooper
Journal:  Dig Dis Sci       Date:  2016-06-01       Impact factor: 3.199

View more
  8 in total

1.  Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis.

Authors:  Swathi Eluri; Sara R Selitsky; Irina Perjar; Johnathan Hollyfield; Renee Betancourt; Cara Randall; Spencer Rusin; John T Woosley; Nicholas J Shaheen; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-10       Impact factor: 11.382

2.  Subcutaneous immunotherapy in patients with eosinophilic esophagitis.

Authors:  Benjamin S Robey; Swathi Eluri; Craig C Reed; Maya R Jerath; Michelle L Hernandez; Scott P Commins; Evan S Dellon
Journal:  Ann Allergy Asthma Immunol       Date:  2019-03-02       Impact factor: 6.347

Review 3.  Allergies and Eosinophilic Esophagitis-Current Updates for the Pediatric Gastroenterologist.

Authors:  Prerana Williamson; Seema Aceves
Journal:  Curr Gastroenterol Rep       Date:  2019-11-20

Review 4.  Allergic components of eosinophilic esophagitis.

Authors:  Jonathan Spergel; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2018-07       Impact factor: 10.793

Review 5.  Does Aeroallergen Sensitization Cause or Contribute to Eosinophilic Esophagitis?

Authors:  Jesus R Guajardo; Melissa A Zegarra-Bustamante; Edward G Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

Review 6.  Eosinophilic esophagitis in children: Updates and practical aspects of management for allergists in a non-tertiary care private practice setup.

Authors:  Ejaz Yousef; Yelena Korotkaya; Alyson B Simpson
Journal:  Allergy Asthma Proc       Date:  2022-01-01       Impact factor: 2.587

Review 7.  The Role of the Environment in Eosinophilic Esophagitis.

Authors:  Paul J Dowling; Hannah Neuhaus; Brooke I Polk
Journal:  Clin Rev Allergy Immunol       Date:  2019-12       Impact factor: 8.667

Review 8.  What Is the Relationship Between Eosinophilic Esophagitis (EoE) and Aeroallergens? Implications for Allergen Immunotherapy.

Authors:  Maureen Egan; Dan Atkins
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-16       Impact factor: 4.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.